14.24
                                            
                                Panoramica
                                Notizia
                                Cronologia dei prezzi
                                    Catena di opzioni
                                Financials
                                    Perché KVUE Giù?
                                Forum
                                Previsione
                                    Storia dei dividendi
                        
                        Kenvue Inc Borsa (KVUE) Ultime notizie
Traders Purchase Large Volume of Call Options on Kenvue (NYSE:KVUE) - MarketBeat
Kenvue Inc. (NYSE:KVUE) Announces $0.21 Quarterly Dividend - MarketBeat
Hold Ratings, High Rewards? 3 Stocks That Could Defy Expectations - MarketBeat
Texas sues Johnson & Johnson, Kenvue over alleged misleading marketing of Tylenol - Compliance Week
Rising to Defend Its Billion-Dollar Tylenol Brand, Kenvue Lures CMO from Mondelēz - ADWEEK
Kenvue Faces Political and Legal Storm Over Tylenol Autism Claims - DesignRush
Will Kenvue Inc. stock hit analyst forecastsMarket Movers & Verified Technical Signals - newser.com
Kenvue stock hits 52-week low at 14.04 USD - Investing.com
Kenvue stock hits 52-week low at 14.04 USD By Investing.com - Investing.com Canada
Kenvue taps Jon Halvorson as new chief marketing officer - Mass Market Retailers
Earnings Preview: Kenvue (KVUE) Q3 Earnings Expected to Decline - Yahoo! Finance Singapore
Jefferies Lowers Kenvue (KVUE) PT to $23, Cites Macroeconomic Headwinds for Consumer Health - Yahoo Finance
The Escalator: Organon, Kenvue, Real Chemistry and more - Medical Marketing and Media
What valuation ratios show for Kenvue Inc. (J4D) stockJuly 2025 Recap & Advanced Technical Signal Analysis - newser.com
Whalen Wealth Management Inc. Acquires New Position in Kenvue Inc. $KVUE - MarketBeat
Tick level data insight on Kenvue Inc. volatilityWeekly Loss Report & Weekly High Return Forecasts - newser.com
How strong is Kenvue Inc. stock earnings growth2025 Performance Recap & AI Powered Buy/Sell Recommendations - newser.com
Does Kenvue (KVUE) Balance Legal Risks and Payouts With a Prudent Capital Allocation Strategy? - simplywall.st
Understanding Kenvue Inc.’s price movementJuly 2025 News Drivers & Consistent Growth Stock Picks - newser.com
Wealthfront Advisers LLC Has $3.41 Million Stock Holdings in Kenvue Inc. $KVUE - MarketBeat
Kenvue (KVUE) Expected to Announce Earnings on Thursday - MarketBeat
Will Kenvue Inc. stock sustain bullish trend into 2025Gap Up & High Yield Stock Recommendations - newser.com
Can trapped investors hope for a rebound in Kenvue Inc.Global Markets & Free Reliable Trade Execution Plans - newser.com
How Kenvue Inc. stock performs in weak economyForecast Cut & Technical Pattern Recognition Alerts - newser.com
Kenvue: Remains A Sell Until The Dividend Is Cut (NYSE:KVUE) - Seeking Alpha
Leading vs lagging indicators on Kenvue Inc. performanceJuly 2025 Patterns & Consistent Profit Alerts - newser.com
Real time scanner hits for Kenvue Inc. explainedEarnings Recap Summary & Consistent Income Trade Recommendations - newser.com
How geopolitical risks impact Kenvue Inc. stock2025 Institutional Moves & Fast Moving Market Watchlists - newser.com
PRODUCTS LIABILITY (DRUGS)—Tex. Dist.: Texas cites twenty-six epidemiological studies in Tylenol marketing suit against Johnson & Johnson, Kenvue - VitalLaw.com
Paxton sues Johnson & Johnson, Kenvue over Tylenol marketing to pregnant women - crossroadstoday.com
US health chief says there is not enough data to show Tylenol causes autism - Reuters
RFK Jr. says Tylenol in pregnancy, autism link is 'very suggestive' - Seeking Alpha
Texas Attorney General Sues Tylenol Makers Over Alleged Autism Risk - Law Commentary
Kenvue: Temporary Headwinds Don't Derail Its Consumer Health Dominance And 5.5% Dividend Yield - Seeking Alpha
Kenvue to tap Jon Halvorson as new chief marketing officer - Medical Marketing and Media
Texas AG sues J&J, Kenvue over Tylenol pregnancy warnings - NJBIZ
Mixed options sentiment in Kenvue Inc with shares down 2.72% - TipRanks
Deutsche Bank Lowers Kenvue (KVUE) PT to $18, Keeps a Hold Rating - Insider Monkey
December 2026 Options Now Available For Kenvue (KVUE) - Nasdaq
Texas Tylenol Lawsuit Accuses J&J of Failing To Warn of Autism Risks - AboutLawsuits.com
Kenvue Hires P&G Exec to Aid Rebound From Tylenol Fallout - Bloomberg.com
The Scoop: Amazon’s layoff memo cuts through public speculation - PR Daily
Texas Sues Tylenol Over Alleged Autism Link - Northwest Signal
Kenvue Keeps Quarterly Dividend at $0.2075 a Share, Payable Nov. 26 to Holders of Record Nov. 12 - MarketScreener
Trump Trade: Texas sues Kenvue, J&J over Tylenol autism risk - TipRanks
Canaccord downgrades Tylenol maker Kenvue as legal risks cloud turnaround - Investing.com
Kenvue Inc. Declares Quarterly Cash Dividend, Payable on November 26, 2025 - MarketScreener
Will Kenvue Inc. stock outperform tech sector in 2025Buy Signal & Breakout Confirmation Trade Signals - newser.com
Mizuho Markets Americas LLC Decreases Stock Holdings in Kenvue Inc. $KVUE - MarketBeat
Canaccord Genuity Downgrades Kenvue to Hold From Buy, Adjusts Price Target to $15 From $26 - MarketScreener
Kenvue downgraded to Hold at Canaccord amid negative headlines - TipRanks
Kenvue Declares Quarterly Cash Dividend - Bluefield Daily Telegraph
Kenvue (KVUE): Assessing Valuation as Legal Risks and Leadership Shifts Raise New Questions - Yahoo Finance
Texas Sues Kenvue, Alleging Deceptive Tylenol Marketing - The Business of Fashion
Teacher Retirement System of Texas Has $18.91 Million Stock Holdings in Kenvue Inc. $KVUE - MarketBeat
D.A. Davidson & CO. Sells 74,699 Shares of Kenvue Inc. $KVUE - MarketBeat
Texas sues Tylenol makers J&J and Kenvue, claiming they hid drug's autism risks | Health | swoknews.com - The Lawton Constitution
Paxton sues Tylenol company over autism claims - Marshall News Messenger
Texas sues Johnson & Johnson over Tylenol autism warningsCHOSUNBIZ - Chosun Biz
Johnson & Johnson, Kenvue slammed with state lawsuit over Tylenol autism claims - Insurance Business America
Texas sues Johnson & Johnson over Tylenol-autism link claims - KEYE
Texas Waves ‘MAHA’ Flag With Complaint Alleging Autism Link To Prenatal Acetaminophen Exposure - Citeline News & Insights
Texas Sues Tylenol Makers, Claiming They Hid Autism Risks - The New York Times
Texas sues Kenvue claiming it hid link between Tylenol and autism - drugdiscoverytrends.com
        Apri su Yahoo
        |
        Apri su Google
            |
            Aperto in Finviz
        |
        Apri in MarketWatch
            |
            Aperto a EDGAR    
        |
        Aperto su Reuters
    
    
                Capitalizzazione:
                 
                  | 
                Volume (24 ore):
                 
            
         
                     
                             Scarica l'app Stockscreener
                    Scarica l'app Stockscreener
                